Mostafa Adam S. has filed 15 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 850000 shares of X4 Pharmaceuticals, Inc ($XFOR) on February 12, 2025.
Activity breakdown: 0 open-market purchases and 10 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | A | Common Stock | 850000 | $0.00 | 850,000.0000 | 201,062,211 | 9999.99% | 0.42% |
| Jan. 23, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | A | Common Stock | 74773 | $0.00 | 74,773.0000 | 201,062,211 | 9999.99% | 0.04% |
| Jan. 24, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | S | Common Stock | 74773 | $0.45 | 0.0000 | 201,062,211 | 100.00% | 0.04% |
| Oct. 4, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | A | Common Stock | 230645 | $0.00 | 230,645.0000 | 6,695,509 | 9999.99% | 3.44% |
| Oct. 7, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | S | Common Stock | 230645 | $0.55 | 0.0000 | 6,695,509 | 100.00% | 3.44% |
| March 11, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | S | Common Stock | 52500 | $0.88 | 0.0000 | 177,812,480 | 100.00% | 0.03% |
| Feb. 13, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | A | Stock Appreciation Right | 523414 | $0.00 | 523,414.0000 | 177,812,480 | 9999.99% | 0.29% |
| Feb. 12, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | S | Common Stock | 27721 | $1.01 | 52,500.0000 | 177,812,480 | 34.56% | 0.02% |
| Nov. 1, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | S | Common Stock | 230645 | $0.73 | 80,221.0000 | 63,525,845 | 74.19% | 0.36% |
| Oct. 31, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | A | Common Stock | 230645 | $0.00 | 310,866.0000 | 63,525,845 | 287.51% | 0.36% |
| June 30, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | S | Common Stock | 2641 | $1.89 | 80,221.0000 | 63,525,845 | 3.19% | 0.00% |
| June 23, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | S | Common Stock | 5417 | $1.93 | 82,862.0000 | 63,525,845 | 6.14% | 0.01% |
| June 15, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | S | Common Stock | 5417 | $2.22 | 88,279.0000 | 63,525,845 | 5.78% | 0.01% |
| March 10, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | S | Common Stock | 52500 | $0.84 | 93,696.0000 | 63,525,845 | 35.91% | 0.08% |
| Feb. 13, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Mostafa Adam S. | Chief Financial Officer | S | Common Stock | 27721 | $0.93 | 146,196.0000 | 63,525,845 | 15.94% | 0.04% |